The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 01, 2016

Filed:

Nov. 13, 2008
Applicants:

Roshantha A. Chandraratna, Laguna Hills, CA (US);

Yang-dar Yuan, Irvine, CA (US);

Inventors:

Roshantha A. Chandraratna, Laguna Hills, CA (US);

Yang-Dar Yuan, Irvine, CA (US);

Assignee:

IO Therapeutics, Inc., Laguna Hills, CA (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/38 (2006.01); A61K 31/015 (2006.01); A61K 31/167 (2006.01); A61K 31/192 (2006.01); A61K 31/202 (2006.01); A61K 31/353 (2006.01); A61K 31/382 (2006.01); A61K 31/44 (2006.01); A61K 31/4436 (2006.01); A61K 31/47 (2006.01);
U.S. Cl.
CPC ...
A61K 31/015 (2013.01); A61K 31/167 (2013.01); A61K 31/192 (2013.01); A61K 31/202 (2013.01); A61K 31/353 (2013.01); A61K 31/382 (2013.01); A61K 31/44 (2013.01); A61K 31/4436 (2013.01); A61K 31/47 (2013.01);
Abstract

A method for treating chemo therapy or radiation therapy side effects in a mammal undergoing chemotherapy and/or radiation therapy, the method comprising a step of administering to the mammal a therapeutically effective amount of a RAR antagonist or RAR inverse agonist which binds to receptors of the RARα, RARβ and RARγ subtypes is disclosed. Such side effects include chemoradiotherapy-induced alopecia, chemoradiotherapy-induced thrombocytopenia, chemoradiotherapy-induced leucopenia and chemoradiotherapy-induced neutropenia.


Find Patent Forward Citations

Loading…